The Pharmaceutical Benefits Scheme (PBS) demonstrates complex funding collaboration between government and non-government sectors. What impact does this funding model have on healthcare accessibility?
- PBS subsidies enable broader population access to medicines while pharmaceutical companies maintain research incentives
- Government funding eliminates all costs for prescription medications
- Private pharmaceutical companies receive no financial benefit from the PBS arrangement
- PBS funding only covers medications for public hospital patients